# AstraZeneca Pharmaceuticals LP, Gaithersburg, MD – FDA Inspections

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f2e34b74-3ef4-4f39-8f6f-41eceb3bb779

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Gaithersburg, Maryland. 16 FDA inspections on record, 1 Form 483, last inspected January 14, 2026.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 1000198729
- Address Line 1: 1 Medimmune Way
- City: Gaithersburg
- State: Maryland
- Zip Code: 20878
- Country Name: United States
- Address: 1 Medimmune Way, Gaithersburg, Maryland 20878, United States
- Country: United States

## Related Documents

- FDA Inspection 1299436 - AstraZeneca Pharmaceuticals LP - 2026-01-14 — source: FDA, date: January 14, 2026
- FDA Inspection 1299436 - AstraZeneca Pharmaceuticals LP - 2026-01-14 — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2026
- [FDA Inspection 1254239 - AstraZeneca Pharmaceuticals LP - 2024-10-25](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/da96b405-5d6f-462e-8164-cc589345ae2e) — source: FDA, date: October 25, 2024
- FDA Inspection 1254239 - AstraZeneca Pharmaceuticals LP - 2024-10-25 — classification: No Action Indicated (NAI), source: FDA, date: October 25, 2024
- [483 - AstraZeneca Pharmaceuticals LP - 2024-05-31](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/4a1a7d2c-db13-49cb-bab9-3235ea58515f) — source: FDA, date: May 31, 2024
- [FDA Inspection 1238346 - AstraZeneca Pharmaceuticals LP - 2024-05-31](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f4d9b1b5-b5fa-492a-8363-3e39782013b0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2024
- FDA Inspection 1230136 - AstraZeneca Pharmaceuticals LP - 2024-01-22 — classification: No Action Indicated (NAI), source: FDA, date: January 22, 2024
- FDA Inspection 1211604 - AstraZeneca Pharmaceuticals LP - 2023-07-18 — classification: No Action Indicated (NAI), source: FDA, date: July 18, 2023
- FDA Inspection 1157291 - AstraZeneca Pharmaceuticals LP - 2021-09-30 — classification: No Action Indicated (NAI), source: FDA, date: September 30, 2021
- FDA Inspection 1136278 - AstraZeneca Pharmaceuticals LP - 2021-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2021
- FDA Inspection 1132938 - AstraZeneca Pharmaceuticals LP - 2020-10-27 — classification: No Action Indicated (NAI), source: FDA, date: October 27, 2020

## Related Companies

- [SUN PHARMACEUTICAL INDUSTRIES INC](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/35896832-2f85-4257-b499-6aa39d1d5f3b)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/fbb2cea0-65e4-4da9-9c5f-eea90c33a84f)
- [Incyte Corporation](https://www.keypedia.com/companies/incyte-corporation/2f3187b3-71fc-4c7d-95bf-d829cc4eceec)
- [Medpace Inc](https://www.keypedia.com/companies/medpace-inc/e09bfcb9-1613-4cc0-8434-8913be0f770d)
- [Sanofi US Services, Inc.](https://www.keypedia.com/companies/sanofi-us-services-inc/f353cbc0-ab3f-4c16-86a1-b9ee2af4e4a1)
- [Sagent Pharmaceuticals](https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd)
- [ICON PLC](https://www.keypedia.com/companies/icon-plc/e6c2ba99-0466-446d-8580-ecfca845adba)
- [Helena Rodbard, MD](https://www.keypedia.com/companies/helena-rodbard-md/e0e5b967-b618-4510-8e8e-939b77eecdfa)
- [Woodhaven Pharmacy Services, LLC dba Remedi SeniorCare](https://www.keypedia.com/companies/woodhaven-pharmacy-services-llc-dba-remedi-seniorcare/9d8a51c9-d9c4-41ae-bda7-525cbcc16d55)
- [Marcia I. Canto, M.D.](https://www.keypedia.com/companies/marcia-i-canto-md/d9007a1b-67a9-4a3c-92ea-ec5d19bb72c1)

## Related Officers

- [Pharmaceutical Scientist](https://www.keypedia.com/people/ekaterina-allen/760a7817-8e5b-45f9-82ee-db6ca139a92e)
- [James R. Birkenstamm](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)